SEARCH HEALTH CONDITIONS BY ALPHABETS
Osteolytic Bone Lesions of Multiple Myeloma
Medications for Osteolytic Bone Lesions of Multiple Myeloma
Other titles: Multiple Myeloma, Osteolytic Bone Lesions
About Osteolytic Bone Lesions of Multiple Myeloma: Osteolytic Bone Lesions of Multiple Myeloma make reference to areas of varicose bone due to multiple myeloma -- a sort of cancer caused by malignant plasma cells.
Drugs Used to Treat Osteolytic Bone Lesions of Multiple Myeloma
This set of medications come in some way related to, or utilized at the treating this condition.
| Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Zometa | Rx | D | N | 5 testimonials | 5.2 | ||
Generic title: zoledronic acid systemic Medication class: bisphosphonates For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Aredia | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: pamidronate systemic Medication class: bisphosphonates For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| zoledronic acid | Rx | D | N | 6 testimonials | 5.8 | ||
Generic title: zoledronic acid systemic Brand titles: Zometa, Reclast, Aclasta Medication class: bisphosphonates For users: dosage, interactions, For specialists: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| pamidronate | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: pamidronate systemic Brand title: Aredia Medication class: bisphosphonates For users: dosage, interactions, For specialists: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Xgeva | Rx | X | N | Insert inspection | 0.0 | ||
Generic title: denosumab systemic Medicine class: mixed bone resorption inhibitors For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| denosumab | Rx | X | N | Insert inspection | 0.0 | ||
Generic title: denosumab systemic Brand title: Xgeva Medicine class: mixed bone resorption inhibitors For users: dosage, interactions, For specialists: a Z Drug Facts, AHFS DI Monograph | |||||||
| Reclast | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: zoledronic acid systemic Medication class: bisphosphonates For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Aclasta | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: zoledronic acid systemic Medication class: bisphosphonates For consumers: dosage, interactions, negative effects | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication may not be accepted by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (also there`s no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal research studies have shown an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in pregnant women clearly outweigh potential gains. |
| N | FDA have not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| Inch | features a high possibility of misuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| Two | features a high possibility of misuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can result in acute physical or emotional dependency. |
| 3 | includes a potential for abuse less than those in programs 1 and two. Features a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a low potential for abuse in accordance with those in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 3. |
| 5 | features a low potential for abuse in accordance with those in program 4. Features a currently accepted medical use in treatment in the United States. Abuse can lead to limited physical dependence or psychological dependence relative to individuals in program 4 days. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask your healthcare provider to ensure the information relates to your personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
